Allarity Therapeutics wins Japanese patent for stenoparib diagnostic
The company said Japan's patent office granted a key patent for its stenoparib-specific DRP® companion diagnostic, extending protection in Japan into 2039.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.